Table 1.
Parameter | Everolimus | Axitinib |
---|---|---|
Dose | Oral, 10 mg, once daily16 | Oral, 5 mg, twice daily 12 h apart17 |
Adherence | 0.76 MPR9 | 0.76 MPR9 |
Exposure | Median AUC: 127 µg×h/L18 | Median AUC: 375 ng×h/mL20 |
Effect of exposure on outcomes | Cmin <10 ng/mL=4.47 median PFS Cmin 10–30 ng/mL=5.52 median PFS Cmin >30 ng/mL=5.36 median PFS24 |
PFS HR based on AUC level: 0.90920 |
Abbreviations: AUC, area under the plasma concentration–time curve; Cmin, minimum blood or trough concentration; HR, hazard ratio; MPR, medication possession ratio; PFS, progression-free survival.